Literature DB >> 17551269

[Primary glomerulopathies in Lithuania: a retrospective analysis of renal biopsy cases (2000-2006)].

Sandra Beitnaraite1, Edvardas Kovaliūnas, Arvydas Laurinavicius.   

Abstract

A retrospective study of 1363 native kidney biopsies, performed at Lithuanian nephrology units and investigated at the National Center of Pathology during the period of 2000-2006, was carried out. Inflammatory glomerulopathies constituted 63.6% of all primary glomerulopathies (834 cases); IgA nephropathy was the most frequent disease (35.0%). The incidence of membranoproliferative glomerulonephritis decreased from 22.6% reported in Lithuania previously (1995-1999) to 16.7% in this study; however, it was still higher compared to most European countries. Extracapillary proliferative glomerulonephritis and diffuse endocapillary proliferative glomerulonephritis accounted for 9.1% and 4.4%, respectively. Noninflammatory glomerulopathies were relatively rare: focal and segmental glomerulosclerosis made up 14.8%; minimal change disease, 9.7%; membranous nephropathy, 7.4%. However, their incidence increased compared to the previously reported in 1995-1999 (9.5%, 5.8%, and 4.3%, respectively). It can be concluded that inflammatory glomerulopathies were predominant in Lithuania in 2000-2006; however, these glomerulopathies were less prominent as compared to the previously reported data in 1995-1999.

Entities:  

Mesh:

Year:  2007        PMID: 17551269

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  2 in total

1.  Nationwide renal biopsy data in Lithuania 1994-2012.

Authors:  Ernesta Brazdziute; Marius Miglinas; Elita Gruodyte; Janina Priluckiene; Algirdas Tamosaitis; Inga Arune Bumblyte; Vytautas Kuzminskis; Soneta Burbaickaja; Marija Sakalauskienė; Augustina Jankauskienė; Rimante Cerkauskiene; Birute Pundziene; Arvydas Laurinavicius
Journal:  Int Urol Nephrol       Date:  2015-02-17       Impact factor: 2.370

2.  The incidence of possible causes of membranoproliferative glomerulonephritis: a single-center experience.

Authors:  J Pavinic; M Miglinas
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.